Get started
JetEquities

argenx Announces Positive Topline Results from Phase 3 ADAPT Tri

Long
argenx SE (NASDAQ:ARGX)  
JetEquities  
NASDAQ:ARGX   argenx SE
Beyond Technical Analysis
4
0
beyondta
ARGX: argenx SE
2020-05-26 01:00:00
argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.